GB201105660D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB201105660D0
GB201105660D0 GBGB1105660.3A GB201105660A GB201105660D0 GB 201105660 D0 GB201105660 D0 GB 201105660D0 GB 201105660 A GB201105660 A GB 201105660A GB 201105660 D0 GB201105660 D0 GB 201105660D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1105660.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nucana PLC
Original Assignee
Nucana Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucana Biomed Ltd filed Critical Nucana Biomed Ltd
Priority to GBGB1105660.3A priority Critical patent/GB201105660D0/en
Publication of GB201105660D0 publication Critical patent/GB201105660D0/en
Priority to EP18178715.1A priority patent/EP3447061B1/en
Priority to MX2013009815A priority patent/MX339822B/en
Priority to DK16150494.9T priority patent/DK3031812T3/en
Priority to BR112013021986-6A priority patent/BR112013021986B1/en
Priority to ES12709146.0T priority patent/ES2569185T3/en
Priority to SI201231972T priority patent/SI3447061T1/en
Priority to PL18178715T priority patent/PL3447061T3/en
Priority to KR1020137025749A priority patent/KR101885940B1/en
Priority to AU2012223012A priority patent/AU2012223012C1/en
Priority to EP21209926.1A priority patent/EP4023299A1/en
Priority to SG2013062823A priority patent/SG192841A1/en
Priority to SI201230488T priority patent/SI2681227T1/en
Priority to HUE18178715A priority patent/HUE060127T2/en
Priority to PL12709146T priority patent/PL2681227T3/en
Priority to HUE12709146A priority patent/HUE029022T2/en
Priority to PT16150494T priority patent/PT3031812T/en
Priority to ES16150494.9T priority patent/ES2686219T3/en
Priority to CN201280010761.4A priority patent/CN103403013B/en
Priority to PCT/GB2012/050457 priority patent/WO2012117246A1/en
Priority to RS20211549A priority patent/RS62721B1/en
Priority to LTEP18178715.1T priority patent/LT3447061T/en
Priority to HRP20211967TT priority patent/HRP20211967T1/en
Priority to DK18178715.1T priority patent/DK3447061T3/en
Priority to RS20160211A priority patent/RS54776B1/en
Priority to JP2013555935A priority patent/JP5978232B2/en
Priority to CN201510329656.2A priority patent/CN104974206B/en
Priority to US14/000,682 priority patent/US8933053B2/en
Priority to EP12709146.0A priority patent/EP2681227B1/en
Priority to DK12709146.0T priority patent/DK2681227T3/en
Priority to ES18178715T priority patent/ES2903097T3/en
Priority to PT181787151T priority patent/PT3447061T/en
Priority to PL16150494T priority patent/PL3031812T3/en
Priority to CA2828326A priority patent/CA2828326C/en
Priority to NZ615270A priority patent/NZ615270A/en
Priority to EP16150494.9A priority patent/EP3031812B1/en
Priority to RU2013143862A priority patent/RU2614406C2/en
Priority to IL228169A priority patent/IL228169A/en
Priority to CL2013002517A priority patent/CL2013002517A1/en
Priority to ZA2013/06468A priority patent/ZA201306468B/en
Priority to HK14105963.6A priority patent/HK1192758A1/en
Priority to US14/560,097 priority patent/US9221866B2/en
Priority to ZA2014/09013A priority patent/ZA201409013B/en
Priority to PH12015500485A priority patent/PH12015500485A1/en
Priority to US14/943,555 priority patent/US9655915B2/en
Priority to HRP20160346TT priority patent/HRP20160346T1/en
Priority to CY20161100360T priority patent/CY1117445T1/en
Priority to SM201600132T priority patent/SMT201600132B/en
Priority to US15/489,884 priority patent/US10022390B2/en
Priority to US16/021,103 priority patent/US10993957B2/en
Priority to US17/223,241 priority patent/US11559542B2/en
Priority to CY20211101114T priority patent/CY1124871T1/en
Priority to US18/095,937 priority patent/US11925658B2/en
Ceased legal-status Critical Current

Links

GBGB1105660.3A 2011-03-01 2011-04-01 Chemical compounds Ceased GB201105660D0 (en)

Priority Applications (53)

Application Number Priority Date Filing Date Title
GBGB1105660.3A GB201105660D0 (en) 2011-04-01 2011-04-01 Chemical compounds
EP18178715.1A EP3447061B1 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
MX2013009815A MX339822B (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer.
DK16150494.9T DK3031812T3 (en) 2011-03-01 2012-02-29 CHEMICAL COMPOUNDS
BR112013021986-6A BR112013021986B1 (en) 2011-03-01 2012-02-29 5-FLUORO-2'-DEOXYURIDINE PHOSPHORAMIDATE DERIVATIVES, ITS USES AND PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD
ES12709146.0T ES2569185T3 (en) 2011-03-01 2012-02-29 5-Fluoro-2'-Deoxyuridine phosphoramidate derivatives for use in cancer treatment
SI201231972T SI3447061T1 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PL18178715T PL3447061T3 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
KR1020137025749A KR101885940B1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
AU2012223012A AU2012223012C1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
EP21209926.1A EP4023299A1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
SG2013062823A SG192841A1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
SI201230488T SI2681227T1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
HUE18178715A HUE060127T2 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PL12709146T PL2681227T3 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
HUE12709146A HUE029022T2 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PT16150494T PT3031812T (en) 2011-03-01 2012-02-29 Chemical compounds
ES16150494.9T ES2686219T3 (en) 2011-03-01 2012-02-29 Chemical compounds
CN201280010761.4A CN103403013B (en) 2011-03-01 2012-02-29 Be used for the treatment of the Phosphoramidate derivatives of the FdUrd of cancer
PCT/GB2012/050457 WO2012117246A1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
RS20211549A RS62721B1 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
LTEP18178715.1T LT3447061T (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
HRP20211967TT HRP20211967T1 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
DK18178715.1T DK3447061T3 (en) 2011-03-01 2012-02-29 PHARMACEUTICAL FORMULATION INCLUDING A PHOSPHORAMIDATE DERIVATIVE OF 5-FLUORO-2'-DEOXYURIDINE FOR USE IN CANCER TREATMENT
RS20160211A RS54776B1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
JP2013555935A JP5978232B2 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in cancer therapy
CN201510329656.2A CN104974206B (en) 2011-03-01 2012-02-29 The Phosphoramidate derivatives of FdUrd for treating cancer
US14/000,682 US8933053B2 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
EP12709146.0A EP2681227B1 (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
DK12709146.0T DK2681227T3 (en) 2011-03-01 2012-02-29 PHOSPHORAMIDATE DERIVATIVES OF 5-FLUOR-2'-DEOXYURIDINE FOR USE IN CANCER TREATMENT
ES18178715T ES2903097T3 (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a 5-fluoro-2'-deoxyuridine phosphoramidate derivative for use in the treatment of cancer
PT181787151T PT3447061T (en) 2011-03-01 2012-02-29 Pharmaceutical formulation comprising a phosphoramidate derivative of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PL16150494T PL3031812T3 (en) 2011-03-01 2012-02-29 Chemical compounds
CA2828326A CA2828326C (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the treatment of cancer
NZ615270A NZ615270A (en) 2011-03-01 2012-02-29 Phosphoramidate derivatives of 5 - fluoro - 2 ‘ - deoxyuridine for use in the treatment of cancer
EP16150494.9A EP3031812B1 (en) 2011-03-01 2012-02-29 Chemical compounds
RU2013143862A RU2614406C2 (en) 2011-03-01 2012-02-29 Phosphorus amidate derivatives of 5-fluoro-2'-deoxyuridine applicable for treating cancer
IL228169A IL228169A (en) 2011-03-01 2013-08-28 Phosphoramidate derivatives of 5-fluoro-2-deoxyuridine for use in the treatment of cancer
CL2013002517A CL2013002517A1 (en) 2011-03-01 2013-08-30 Compounds derived from 5-fluoro-2'-deoxyuridine phosphoramidate; preparation procedure; pharmaceutical composition that includes them; its use in the treatment or prophylaxis of cancer.
ZA2013/06468A ZA201306468B (en) 2011-03-01 2013-09-09 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
HK14105963.6A HK1192758A1 (en) 2011-03-01 2014-06-23 Phosphoramidate derivatives of 5-fluoro-2-deoxyuridine for use in the treatment of cancer 5--2-
US14/560,097 US9221866B2 (en) 2011-03-01 2014-12-04 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
ZA2014/09013A ZA201409013B (en) 2011-03-01 2014-12-09 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
PH12015500485A PH12015500485A1 (en) 2011-03-01 2015-03-05 Phosphoramidate derivatives of 5 - fluoro - 2` - deoxyuridine for use in the treatment of cancer
US14/943,555 US9655915B2 (en) 2011-03-01 2015-11-17 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
HRP20160346TT HRP20160346T1 (en) 2011-03-01 2016-04-05 Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
CY20161100360T CY1117445T1 (en) 2011-03-01 2016-04-27 5-FLUORO-2´-DEOXYURIDINE PHOSPHORAMIDIC PRODUCTS FOR USE IN CANCER TREATMENT
SM201600132T SMT201600132B (en) 2011-03-01 2016-05-06 PHOSPHORAMIDATE DERIVATIVES OF 5-FLUORUM-2'-DESOSSIURIDINE FOR USE IN CANCER TREATMENT
US15/489,884 US10022390B2 (en) 2011-03-01 2017-04-18 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
US16/021,103 US10993957B2 (en) 2011-03-01 2018-06-28 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
US17/223,241 US11559542B2 (en) 2011-03-01 2021-04-06 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer
CY20211101114T CY1124871T1 (en) 2011-03-01 2021-12-17 PHARMACEUTICAL COMPOSITIONS CONTAINING PHOSPHORAMIDE DERIVATIVES OF 5-FLUORO-2'-DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCER
US18/095,937 US11925658B2 (en) 2011-03-01 2023-01-11 Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1105660.3A GB201105660D0 (en) 2011-04-01 2011-04-01 Chemical compounds

Publications (1)

Publication Number Publication Date
GB201105660D0 true GB201105660D0 (en) 2011-05-18

Family

ID=44071905

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1105660.3A Ceased GB201105660D0 (en) 2011-03-01 2011-04-01 Chemical compounds

Country Status (1)

Country Link
GB (1) GB201105660D0 (en)

Similar Documents

Publication Publication Date Title
PT3031812T (en) Chemical compounds
IL233154A0 (en) Compounds
HK1175650A1 (en) Chemical compounds
GB201109763D0 (en) Compounds
GB201106395D0 (en) Compounds
EP2549868A4 (en) Chemical compounds
ZA201306857B (en) Mesogen-containing compounds
EP2635279A4 (en) Chemical compounds
GB201016855D0 (en) Chemical compounds
GB201122139D0 (en) Compounds
GB201107197D0 (en) Compounds
EP2741746A4 (en) Chemical compounds
GB201201566D0 (en) New chemical compounds
GB201008290D0 (en) Chemical compounds
HK1191326A1 (en) Azaspirodecanone compounds
EP2771011A4 (en) Chemical compounds
EP2661424A4 (en) Chemical compounds
GB201110938D0 (en) Compounds
GB201105659D0 (en) Compounds
GB201118613D0 (en) Compounds
GB201018340D0 (en) Chemical compounds
GB201107719D0 (en) Chemical compounds
GB201105660D0 (en) Chemical compounds
GB201218640D0 (en) Chemical compounds
GB201205979D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)